Article Versions Notes

Gobeil É, Maltais-Payette I, Taba N, Brière F, Ghodsian N, Abner E, Bourgault J, Gagnon E, Manikpurage HD, Couture C, et al. Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease. Metabolites. 2022; 12(5):440. https://doi.org/10.3390/metabo12050440

Gobeil, Émilie, Ina Maltais-Payette, Nele Taba, Francis Brière, Nooshin Ghodsian, Erik Abner, Jérôme Bourgault, Eloi Gagnon, Hasanga D. Manikpurage, Christian Couture, and et al. 2022. "Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease" Metabolites 12, no. 5: 440. https://doi.org/10.3390/metabo12050440

Gobeil, É., Maltais-Payette, I., Taba, N., Brière, F., Ghodsian, N., Abner, E., Bourgault, J., Gagnon, E., Manikpurage, H. D., Couture, C., Mitchell, P. L., Mathieu, P., Julien, F., Corbeil, J., Vohl, M.-C., Thériault, S., Esko, T., Tchernof, A., & Arsenault, B. J. (2022). Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease. Metabolites, 12(5), 440. https://doi.org/10.3390/metabo12050440